...
首页> 外文期刊>The American Journal of the Medical Sciences >Epigallocatechin-3-Gallate: The Prospective Targeting of Cancer Stem Cells and Preventing Metastasis of Chemically-Induced Mammary Cancer in Rats
【24h】

Epigallocatechin-3-Gallate: The Prospective Targeting of Cancer Stem Cells and Preventing Metastasis of Chemically-Induced Mammary Cancer in Rats

机译:EpigallocaTechin-3-gallate:癌症干细胞的前瞻性靶向,预防大鼠化学诱导的乳腺癌转移

获取原文
获取原文并翻译 | 示例

摘要

Abstract Background Cancer stem cells are a subpopulation of tumor cells that are capable of self-renewal, capable of tumor recurrence and metastasis, and in addition are resistant to current cancer therapies. Epigallocatechin-3-gallate is a type of catechin found in green tea that is known for its powerful chemoprotective ability. Hence, this study aimed to investigate the effect of epigallocatechin-3-gallate on 7, 12 dimethylbenzanthracene-induced tumor metastasis, angiogenesis and cancer stem cells. Materials and Methods For this purpose, 3 groups of virgin femal rats with 7,12 dimethylbenzanthracene-induced mammary cancer were treated using epigallocatechin-3-gallate, paclitaxel or their combination. Results It was found that epigallocatechin-3-gallate exhibited significant chemopreventive effects and anti-cancer stem cell activity through several pathways, including a significant decrease in the size and number of tumors per rat, significant amelioration of the oxidative stress markers’ alterations and significant inhibition of CD44, VEGF, Ki-67 and MMP-2 expression associated with a significantly increased expression of caspase-3. Histopathologically, therapy with epigallocatechin-3-gallate resulted in marked necrosis of the neoplastic cells and the tumor masses were mostly replaced by proliferated fibrous tissue so that histological confirmation of a previous tumor was not possible at that site. However, in the combination therapy the neoplastic cells showed marked vacuolation, haphazard arrangement and extensive nuclear pyknosis accompanied with many apoptotic bodies. Therapy with the sole paclitaxel caused variable degrees of necrosis among the neoplastic cells. Additionally, the combination of epigallocatechin-3-gallate and paclitaxel significantly enhanced the later anticancer efficacy. Conclusions Epigallocatechin-3-gallatecould be offered as an unprecedented curative strategy to eradicate cancer.
机译:摘要背景肿瘤干细胞是一类具有自我更新能力、肿瘤复发和转移能力、对现有癌症治疗具有耐药性的肿瘤细胞亚群。表没食子儿茶素没食子酸酯是绿茶中发现的一种儿茶素,以其强大的化学保护能力而闻名。因此,本研究旨在研究表没食子儿茶素没食子酸酯对7,12-二甲基苯并蒽诱导的肿瘤转移、血管生成和肿瘤干细胞的影响。材料和方法为此目的,使用表没食子儿茶素没食子酸酯、紫杉醇或其组合治疗3组7,12-二甲基苯并蒽诱发的乳腺癌的未成年雌性大鼠。结果表没食子儿茶素没食子儿茶素没食子酸酯通过多种途径显示出显著的化学预防作用和抗肿瘤干细胞活性,包括显著减少每只大鼠的肿瘤大小和数量,显著改善氧化应激标记物的改变,显著抑制CD44、VEGF、VEGF的表达,Ki-67和MMP-2的表达与caspase-3的表达显著增加相关。组织病理学上,表没食子儿茶素-3-没食子酸酯治疗导致肿瘤细胞明显坏死,肿瘤肿块大部分被增生的纤维组织取代,因此无法在该部位对以前的肿瘤进行组织学确认。然而,在联合治疗中,肿瘤细胞表现出明显的空泡化、随意排列和广泛的核固缩,并伴有许多凋亡小体。单独使用紫杉醇治疗可导致肿瘤细胞不同程度的坏死。此外,表没食子儿茶素没食子酸酯和紫杉醇的联合使用显著增强了后期抗癌疗效。结论表没食子儿茶素-3-没食子酸酯可作为一种前所未有的根治癌症的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号